Soleno Therapeutics (SLNO) News Today $82.35 +3.64 (+4.62%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$82.91 +0.56 (+0.68%) As of 08/8/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SLNO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Vivo Capital LLC Has $318.55 Million Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)August 9 at 7:11 AM | marketbeat.comCenterBook Partners LP Has $1.17 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)August 9 at 5:54 AM | marketbeat.comSoleno Therapeutics Provides Update on U.S. Launch of VYKAT XR and Reports Second Quarter 2025 Financial ResultsAugust 9 at 2:17 AM | finanznachrichten.deSoleno Therapeutics price target raised to $120 from $115 at TD CowenAugust 9 at 2:17 AM | msn.comGuggenheim Issues Positive Forecast for Soleno Therapeutics (NASDAQ:SLNO) Stock PriceAugust 8 at 10:33 AM | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $110.00August 8 at 9:54 AM | marketbeat.comCarlyle Group Inc. Has $61.45 Million Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)August 8 at 6:43 AM | marketbeat.com72,582 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Bought by Mutual of America Capital Management LLCAugust 8 at 3:20 AM | marketbeat.comSoleno Therapeutics, Inc. (SLNO) Q2 2025 Earnings Call TranscriptAugust 7 at 4:00 AM | seekingalpha.comSoleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports Second Quarter 2025 Financial ResultsAugust 6, 2025 | globenewswire.comSoleno Therapeutics's Earnings: A PreviewAugust 6, 2025 | benzinga.comWestfield Capital Management Co. LP Acquires 329,785 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)August 4, 2025 | marketbeat.comVictory Capital Management Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)August 3, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from AnalystsAugust 3, 2025 | americanbankingnews.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from BrokeragesAugust 3, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Bought by TD Asset Management IncAugust 2, 2025 | marketbeat.comXTX Topco Ltd Boosts Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)August 1, 2025 | marketbeat.comSoleno Therapeutics (SLNO) to Release Quarterly Earnings on WednesdayJuly 30, 2025 | marketbeat.comRoyce & Associates LP Invests $286,000 in Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 30, 2025 | marketbeat.com36,495 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Acquired by Universal Beteiligungs und Servicegesellschaft mbHJuly 30, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Purchases 15,101 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 29, 2025 | marketbeat.comRWC Asset Management LLP Makes New Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 28, 2025 | marketbeat.comBryce Point Capital LLC Decreases Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 28, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI) and Soleno Therapeutics (SLNO)July 27, 2025 | theglobeandmail.comLegato Capital Management LLC Makes New Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 26, 2025 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Raised to "Hold" at Wall Street ZenJuly 26, 2025 | marketbeat.comHere's What Could Help Soleno Therapeutics (SLNO) Maintain Its Recent Price StrengthJuly 23, 2025 | msn.com40,425 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Purchased by Y Intercept Hong Kong LtdJuly 23, 2025 | marketbeat.comReadystate Asset Management LP Buys 49,422 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 22, 2025 | marketbeat.comSoleno Therapeutics’ Vykat XR Exceeds Sales ExpectationsJuly 21, 2025 | msn.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Atle Fund Management ABJuly 19, 2025 | marketbeat.com11 Best Performing Mid Cap Stocks So Far In 2025July 18, 2025 | insidermonkey.comFY2025 EPS Estimates for SLNO Raised by Cantor FitzgeraldJuly 18, 2025 | marketbeat.comBank of New York Mellon Corp Buys 234,649 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 18, 2025 | marketbeat.comSoleno Therapeutics: Fairly Valued Despite M&A ExpectationsJuly 16, 2025 | seekingalpha.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Sold by TimesSquare Capital Management LLCJuly 15, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) is Emerald Advisers LLC's 8th Largest PositionJuly 13, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) is Emerald Mutual Fund Advisers Trust's 7th Largest PositionJuly 12, 2025 | marketbeat.comSoleno Therapeutics Shares Dip Following $200 Million Stock Offering PricingJuly 11, 2025 | msn.comSoleno Therapeutics (NASDAQ:SLNO) Stock Price Expected to Rise, Robert W. Baird Analyst SaysJuly 11, 2025 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Sees Unusually-High Trading Volume - Time to Buy?July 10, 2025 | marketbeat.comSoleno Therapeutics stock dips on proposed $200M offeringJuly 10, 2025 | msn.comSoleno Therapeutics Announces Pricing of $200 Million Public Offering of Common StockJuly 10, 2025 | globenewswire.comSoleno Therapeutics, Inc. Announces $200 Million Public Offering to Fund VYKAT XR Commercialization and R&D ActivitiesJuly 10, 2025 | quiverquant.comQSoleno Therapeutics Announces Proposed $200 Million Public Offering of Common StockJuly 10, 2025 | globenewswire.comSoleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025July 10, 2025 | globenewswire.comSoleno Therapeutics (NASDAQ:SLNO) Sets New 52-Week High - Time to Buy?July 9, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Recommendation of "Buy" by BrokeragesJuly 9, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Lowered by Allspring Global Investments Holdings LLCJuly 6, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells $316,970.80 in StockJuly 4, 2025 | insidertrades.com Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address SLNO Media Mentions By Week SLNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼0.920.50▲Average Medical News Sentiment SLNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼186▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Femasys News Immunovant News Smith & Nephew SNATS News Solventum News Penumbra News Stevanato Group News iRhythm Technologies News Glaukos News Bausch + Lomb News TransMedics Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 8/10/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
